Assessment of corneal topographic, tomographic, densitometric, and biomechanical properties of Fabry patients with ocular manifestations.


Journal

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
ISSN: 1435-702X
Titre abrégé: Graefes Arch Clin Exp Ophthalmol
Pays: Germany
ID NLM: 8205248

Informations de publication

Date de publication:
May 2020
Historique:
received: 07 08 2019
accepted: 27 12 2019
revised: 22 12 2019
pubmed: 10 1 2020
medline: 6 3 2021
entrez: 10 1 2020
Statut: ppublish

Résumé

To investigate whether cornea verticillata affects corneal topography, tomography, densitometry, or biomechanics of Fabry patients with ocular manifestations and to compare these results with those obtained from healthy subjects. This prospective, cross-sectional study included 23 Fabry patients (Fabry group) with cornea verticillata and the 37 age- and sex-matched healthy subjects (control group). After comprehensive ophthalmological examinations, corneal topography, tomography, and densitometry measurements were taken using Pentacam HR and corneal biomechanics were captured via Corvis ST for all participants. All the investigated topographic and tomographic values were similar in the eyes with Fabry disease (FD) and the controls (P > 0.05). The corneal densitometry values of patients with FD were statistically significantly higher in all the concentric zones and layers, except posterior 0-2 mm and posterior 2-6 mm zones, compared to the controls (P < 0.05). The mean values of A1 velocity, A2 velocity, deformation amplitude ratio, Corvis biomechanical index, tomographic and biomechanical index, and Stiffness parameter at the first applanation in the Fabry group were statistically significantly different compared to control group (P < 0.05). However, the mean values of A1 length, A2 length, and the biomechanically corrected intraocular pressure were similar between the groups (P = 0.317, P = 0.819, and P = 0.468; respectively). Although cornea verticillata associated with FD is not considered to affect vision, it is associated with increased light backscattering and reduced corneal transparency as well as altered corneal biomechanical properties.

Identifiants

pubmed: 31915973
doi: 10.1007/s00417-019-04593-8
pii: 10.1007/s00417-019-04593-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1057-1064

Références

Clin Ophthalmol. 2014 Aug 19;8:1555-60
pubmed: 25170250
Acta Ophthalmol. 2015 May;93(3):e193-8
pubmed: 25270375
Cornea. 2014 Dec;33(12):1282-6
pubmed: 25285589
Clin Exp Ophthalmol. 2005 Apr;33(2):164-8
pubmed: 15807825
Br J Ophthalmol. 2016 Jan;100(1):3-8
pubmed: 25677671
Invest Ophthalmol Vis Sci. 2013 Jan 23;54(1):659-65
pubmed: 23307970
Surv Ophthalmol. 2017 May - Jun;62(3):286-301
pubmed: 27890620
J Refract Surg. 2019 Apr 1;35(4):247-252
pubmed: 30984982
Cornea. 2019 May;38(5):595-599
pubmed: 30681520
Retina. 2017 Mar;37(3):592-603
pubmed: 28225726
Cont Lens Anterior Eye. 2004 Dec;27(4):161-70
pubmed: 16303539
Diabetes. 1988 Jul;37(7):867-72
pubmed: 3384185
Eur J Ophthalmol. 2016 Jan-Feb;26(1):18-23
pubmed: 26165332
Lancet. 2008 Oct 18;372(9647):1427-35
pubmed: 18940466
Optom Vis Sci. 2013 Feb;90(2):e63-78
pubmed: 23334311
Eye Contact Lens. 2018 Sep;44 Suppl 1:S92-S96
pubmed: 27749499
Indian J Ophthalmol. 2018 Mar;66(3):373-382
pubmed: 29480246
Cornea. 2017 Nov;36(11):1336-1342
pubmed: 28872516
J Refract Surg. 2017 Jul 1;33(7):434-443
pubmed: 28681902
J Glaucoma. 2016 Sep;25(9):775-9
pubmed: 27513907
Ophthalmology. 2012 Mar;119(3):501-8
pubmed: 22133793
Exp Eye Res. 2006 Oct;83(4):709-20
pubmed: 16720023
Orphanet J Rare Dis. 2010 Nov 22;5:30
pubmed: 21092187
Clin Exp Optom. 2019 Mar;102(2):140-146
pubmed: 30107640
Graefes Arch Clin Exp Ophthalmol. 2018 Jun;256(6):1159-1163
pubmed: 29525839
Cornea. 2017 Apr;36(4):470-475
pubmed: 27841786
Hum Genet. 1999 Jul-Aug;105(1-2):151-6
pubmed: 10480370
Am J Hum Genet. 2006 Jul;79(1):31-40
pubmed: 16773563
Ocul Immunol Inflamm. 2019;27(7):1127-1137
pubmed: 30084704
Acta Ophthalmol. 2019 Dec;97(8):e1098-e1104
pubmed: 31127703
Br J Ophthalmol. 2007 Feb;91(2):210-4
pubmed: 16973664
Ophthalmic Genet. 2003 Sep;24(3):129-39
pubmed: 12868031
Surv Ophthalmol. 2008 Jul-Aug;53(4):416-23
pubmed: 18572058
Cornea. 2015 Jan;34(1):71-7
pubmed: 25393092
Clin Exp Optom. 2011 Jan;94(1):33-42
pubmed: 20718786
Arch Ophthalmol. 1979 Apr;97(4):671-6
pubmed: 106811
Arch Ophthalmol. 1965 Dec;74(6):760-9
pubmed: 5846554

Auteurs

Veysel Cankurtaran (V)

Ophthalmology Department, Mustafa Kemal University, Antakya, Hatay, Turkey. dr.veyselcankurtaran@hotmail.com.

Kemal Tekin (K)

Ophthalmology Department, Ercis State Hospital, Van, Turkey.

Ayse Idil Cakmak (AI)

Ophthalmology Department, Mustafa Kemal University, Antakya, Hatay, Turkey.

Merve Inanc (M)

Ophthalmology Department, Ercis State Hospital, Van, Turkey.

Faruk Hilmi Turgut (FH)

Nephrology Department, Mustafa Kemal University, Antakya, Hatay, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH